Literature DB >> 21306168

Incorporation of a bioactive reverse-turn heterocycle into a peptide template using solid-phase synthesis to probe melanocortin receptor selectivity and ligand conformations by 2D 1H NMR.

Anamika Singh1, Andrzej Wilczynski, Jerry R Holder, Rachel M Witek, Marvin L Dirain, Zhimin Xiang, Arthur S Edison, Carrie Haskell-Luevano.   

Abstract

By use of a solid-phase synthetic approach, a bioactive reverse turn heterocycle was incorporated into a cyclic peptide template to probe melanocortin receptor potency and ligand structural conformations. The five melanocortin receptor isoforms (MC1R-MC5R) are G-protein-coupled receptors (GPCRs) that are regulated by endogenous agonists and antagonists. This pathway is involved in pigmentation, weight, and energy homeostasis. Herein, we report novel analogues of the chimeric AGRP-melanocortin peptide template integrated with a small molecule moiety to probe the structural and functional consequences of the core His-Phe-Arg-Trp peptide domain using a reverse-turn heterocycle. A series of six compounds are reported that result in inactive to full agonists with nanomolar potency. Biophysical structural analysis [2D (1)H NMR and computer-assisted molecular modeling (CAMM)] were performed on selected analogues, resulting in the identification that these peptide-small molecule hybrids possessed increased flexibility and fewer discrete conformational families compared to the reference peptide and result in a novel template for further structure-function studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21306168      PMCID: PMC3076140          DOI: 10.1021/jm101425m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  59 in total

1.  Design and pharmacology of peptoids and peptide-peptoid hybrids based on the melanocortin agonists core tetrapeptide sequence.

Authors:  Jerry Ryan Holder; Rayna M Bauzo; Zhimin Xiang; Joseph Scott; Carrie Haskell-Luevano
Journal:  Bioorg Med Chem Lett       Date:  2003-12-15       Impact factor: 2.823

2.  Effect of alpha- and betamelanocyte stimulating hormones on the skin colour of man.

Authors:  A B LERNER; J S MCGUIRE
Journal:  Nature       Date:  1961-01-21       Impact factor: 49.962

3.  Design of peptides, proteins, and peptidomimetics in chi space.

Authors:  V J Hruby; G Li; C Haskell-Luevano; M Shenderovich
Journal:  Biopolymers       Date:  1997       Impact factor: 2.505

4.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

5.  Induction of sexual excitement by the action of adrenocorticotrophic hormone in brain.

Authors:  A Bertolini; W Vergoni; G L Gessa; W Ferrari
Journal:  Nature       Date:  1969-02-15       Impact factor: 49.962

6.  A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse.

Authors:  A A Butler; R A Kesterson; K Khong; M J Cullen; M A Pelleymounter; J Dekoning; M Baetscher; R D Cone
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

7.  The cloning of a family of genes that encode the melanocortin receptors.

Authors:  K G Mountjoy; L S Robbins; M T Mortrud; R D Cone
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

8.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

Authors:  K G Mountjoy; M T Mortrud; M J Low; R B Simerly; R D Cone
Journal:  Mol Endocrinol       Date:  1994-10

9.  Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA.

Authors:  V Chhajlani; J E Wikberg
Journal:  FEBS Lett       Date:  1992-09-14       Impact factor: 4.124

10.  4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.

Authors:  T K Sawyer; P J Sanfilippo; V J Hruby; M H Engel; C B Heward; J B Burnett; M E Hadley
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  10 in total

1.  A Macrocyclic Agouti-Related Protein/[Nle4,DPhe7]α-Melanocyte Stimulating Hormone Chimeric Scaffold Produces Subnanomolar Melanocortin Receptor Ligands.

Authors:  Mark D Ericson; Katie T Freeman; Sathya M Schnell; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2017-01-17       Impact factor: 7.446

2.  Synthesis and Pharmacology of α/β(3)-Peptides Based on the Melanocortin Agonist Ac-His-dPhe-Arg-Trp-NH2 Sequence.

Authors:  Anamika Singh; Srinivasa R Tala; Viktor Flores; Katie Freeman; Carrie Haskell-Luevano
Journal:  ACS Med Chem Lett       Date:  2015-04-08       Impact factor: 4.345

3.  Structure-activity relationships of peptides incorporating a bioactive reverse-turn heterocycle at the melanocortin receptors: identification of a 5800-fold mouse melanocortin-3 receptor (mMC3R) selective antagonist/partial agonist versus the mouse melanocortin-4 receptor (mMC4R).

Authors:  Anamika Singh; Marvin Dirain; Rachel Witek; James R Rocca; Arthur S Edison; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2013-03-25       Impact factor: 7.446

4.  1,2,3-Triazole Rings as a Disulfide Bond Mimetic in Chimeric AGRP-Melanocortin Peptides: Design, Synthesis, and Functional Characterization.

Authors:  Srinivasa R Tala; Anamika Singh; Cody J Lensing; Sathya M Schnell; Katie T Freeman; James R Rocca; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2018-01-18       Impact factor: 4.418

5.  Receptor selectivity from minimal backbone modification of a polypeptide agonist.

Authors:  Shi Liu; Ross W Cheloha; Tomoyuki Watanabe; Thomas J Gardella; Samuel H Gellman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-15       Impact factor: 11.205

6.  Similarity analysis, synthesis, and bioassay of antibacterial cyclic peptidomimetics.

Authors:  Workalemahu M Berhanu; Mohamed A Ibrahim; Girinath G Pillai; Alexander A Oliferenko; Levan Khelashvili; Farukh Jabeen; Bushra Mirza; Farzana Latif Ansari; Ihsan Ul-Haq; Said A El-Feky; Alan R Katritzky
Journal:  Beilstein J Org Chem       Date:  2012-07-24       Impact factor: 2.883

7.  Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin.

Authors:  Chia Wen Liu; Wen Jen Lin
Journal:  Int J Nanomedicine       Date:  2012-08-29

8.  Synthesis, biophysical, and pharmacological evaluation of the melanocortin agonist AST3-88: modifications of peptide backbone at Trp 7 position lead to a potent, selective, and stable ligand of the melanocortin 4 receptor (MC4R).

Authors:  Anamika Singh; Marvin L Dirain; Andrzej Wilczynski; Chi Chen; Blake A Gosnell; Allen S Levine; Arthur S Edison; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2014-08-26       Impact factor: 4.418

9.  Investigation of the novel lead of melanocortin 1 receptor for pigmentary disorders.

Authors:  Hsin-Chieh Tang; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-17       Impact factor: 2.629

10.  Identification of tetrapeptides from a mixture based positional scanning library that can restore nM full agonist function of the L106P, I69T, I102S, A219V, C271Y, and C271R human melanocortin-4 polymorphic receptors (hMC4Rs).

Authors:  Erica M Haslach; Huisuo Huang; Marvin Dirain; Ginamarie Debevec; Phaedra Geer; Radleigh G Santos; Marc A Giulianotti; Clemencia Pinilla; Jon R Appel; Skye R Doering; Michael A Walters; Richard A Houghten; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2014-05-14       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.